ASX - Delayed Quote AUD

Paradigm Biopharmaceuticals Limited (PAR.AX)

Compare
0.2100 +0.0050 (+2.44%)
At close: October 25 at 4:10 PM GMT+11

Valuation Measures

Annual
Monthly
Currency in AUD
Download
Current
Market Cap 73.52M
Enterprise Value 55.93M
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales 936.01
Price/Book 3.09
Enterprise Value/Revenue 850.05
Enterprise Value/EBITDA -6.78
-

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 6/30/2024
Most Recent Quarter (mrq) 6/30/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -86.16%
Return on Equity (ttm) -151.39%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA -64.97M
Net Income Avi to Common (ttm) -58.65M
Diluted EPS (ttm) -0.2000
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 17.87M
Total Cash Per Share (mrq) 0.05
Total Debt (mrq) 239.33k
Total Debt/Equity (mrq) 1.00%
Current Ratio (mrq) 7.22
Book Value Per Share (mrq) 0.07

Cash Flow Statement

Operating Cash Flow (ttm) -65.94M
Levered Free Cash Flow (ttm) -48.04M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.94
52 Week Range 3 -64.89%
S&P 500 52-Week Change 3 39.39%
52 Week High 3 0.5982
52 Week Low 3 0.1650
50-Day Moving Average 3 0.2241
200-Day Moving Average 3 0.2797

Share Statistics

Avg Vol (3 month) 3 972.41k
Avg Vol (10 day) 3 1.48M
Shares Outstanding 5 350.07M
Implied Shares Outstanding 6 350.36M
Float 8 311.87M
% Held by Insiders 1 13.75%
% Held by Institutions 1 17.18%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers